e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Formative Research
- 1 JMIR Infodemiology
- 1 JMIR Public Health and Surveillance
- 1 JMIR Research Protocols
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
In New Zealand, 1.06% of adolescents received stimulants in 2016, an increase of 41.3% from 0.75% in 2011 [6]. Denmark observed a trend in stimulant prescriptions rising from 0.31 per 1000 person-years in 1996 to 7.29 per 1000 person-years in 2010 [7]. In Switzerland, data on stimulant prescription rates is scarce. A Swiss study from 2015 found a lifetime prevalence of stimulants and other substances enhancing cognitive abilities of about 1.4% in employees and students [8].
JMIR Public Health Surveill 2025;11:e53957
Download Citation: END BibTex RIS
Specifically, certain substances have significant use among gamers, with caffeine, energy drinks, and prescription stimulants commonly used for performance enhancement [15,16]. Recent studies have found 40% of adult gamers use performance enhancing drugs [17].
JMIR Infodemiology 2024;4:e58201
Download Citation: END BibTex RIS
The use of other substances such as alcohol, stimulants, heroin or opiates, and nicotine is also assessed and described in terms of frequency, method of consumption, and risk of disordered use [105,155,156].
Sleep health outcomes include the self-reporting of sleep duration [157], sleep quality [157], and sleep-related problems (eg, apnea and trouble falling asleep or insomnia) [158].
JMIR Res Protoc 2023;12:e48548
Download Citation: END BibTex RIS
Another participant explained the following:
I'll do it [use stimulants] pretty often, then I'll stop for a year or two, then it's like, ‘Oh, I miss the feeling’ and I’ll go back to it. So, since I’ve been home more, I feel like I have used [stimulants] more than I have in the couple months prior to that per se.
JMIR Form Res 2022;6(5):e30897
Download Citation: END BibTex RIS
We developed three personas—one each for stimulants, opioids, and cannabis—that depicted a hypothetical patient with several DUD symptoms who was interested in learning about options for help (Multimedia Appendix 1). We presented one persona per participant. We also used storyboards [50], which used illustrated panels to show core features of candidate workflow designs.
The storyboards showed alternative scenarios to support patients’ app use.
J Med Internet Res 2021;23(7):e25866
Download Citation: END BibTex RIS